These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10472514)

  • 1. A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
    Rush CR; Ali JA
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):257-65. PubMed ID: 10472514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
    Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
    J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of quazepam and triazolam on cognitive-neuromotor performance.
    Nikaido AM; Ellinwood EH
    Psychopharmacology (Berl); 1987; 92(4):459-64. PubMed ID: 2888152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
    Rush CR; Griffiths RR
    J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects in humans after repeated administrations of zolpidem and triazolam.
    Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
    Rush CR; Baker RW; Wright K
    Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
    Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
    J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute performance-impairing and subject-rated effects of triazolam and temazepam, alone and in combination with ethanol, in humans.
    Simpson CA; Rush CR
    J Psychopharmacol; 2002 Mar; 16(1):23-34. PubMed ID: 11949768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the acute behavioral effects of triazolam and temazepam in normal volunteers.
    Rush CR; Higgins ST; Hughes JR; Bickel WK
    Psychopharmacology (Berl); 1993; 112(4):407-14. PubMed ID: 7871050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative-stimulus effects of triazolam in women and men.
    Vansickel AR; Hays LR; Rush CR
    Am J Drug Alcohol Abuse; 2006; 32(3):329-49. PubMed ID: 16864467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.
    Mintzer MZ; Frey JM; Yingling JE; Griffiths RR
    Behav Pharmacol; 1997 Nov; 8(6-7):561-74. PubMed ID: 9832970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and rebound during and after short-term administration of quazepam, triazolam and placebo to healthy human volunteers.
    Lee A; Lader M
    Int Clin Psychopharmacol; 1988 Jan; 3(1):31-47. PubMed ID: 2895786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test: comparisons with triazolam and quazepam.
    Cooper SJ
    Eur J Pharmacol; 1986 Jan; 120(3):257-65. PubMed ID: 3753939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trazodone and triazolam: acute subject-rated and performance-impairing effects in healthy volunteers.
    Rush CR; Madakasira S; Hayes CA; Johnson CA; Goldman NH; Pazzaglia PJ
    Psychopharmacology (Berl); 1997 May; 131(1):9-18. PubMed ID: 9181630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
    Rush CR; Frey JM; Griffiths RR
    Psychopharmacology (Berl); 1999 Jul; 145(1):39-51. PubMed ID: 10445371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI
    J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
    Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
    Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.